ID: ALA2252046

Max Phase: Preclinical

Molecular Formula: C12H10Br2N4O

Molecular Weight: 386.05

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC12CC(N/C(=N/C#N)N1)c1cc(Br)cc(Br)c1O2

Standard InChI:  InChI=1S/C12H10Br2N4O/c1-12-4-9(17-11(18-12)16-5-15)7-2-6(13)3-8(14)10(7)19-12/h2-3,9H,4H2,1H3,(H2,16,17,18)

Standard InChI Key:  ORRNTENYTHCFSG-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 386.05

Molecular Weight (Monoisotopic): 383.9221

AlogP: 2.78

#Rotatable Bonds: 0

Polar Surface Area: 69.44

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 3.19

CX LogD: 3.19

Aromatic Rings: 1

Heavy Atoms: 19

QED Weighted: 0.67

Np Likeness Score: 0.07

References

1. Finkelstein BL, Benner EA, Hendrixson MC, Kranis KT, Rauh JJ, Sethuraman MR, McCann SF..  (2002)  Tricyclic cyanoguanidines: synthesis, site of action and insecticidal activity of a novel class of reversible acetylcholinesterase inhibitors.,  10  (3): [PMID:11814848] [10.1016/s0968-0896(01)00326-1]

Source

Source(1):

• Scientific Literature